| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |